Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2010

01-12-2010 | Research Report

A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland

Authors: Dorota Piekutowska-Abramczuk, Rikke K. J. Olsen, Jolanta Wierzba, Ewa Popowska, Dorota Jurkiewicz, Elżbieta Ciara, Mariusz Ołtarzewski, Wanda Gradowska, Jolanta Sykut-Cegielska, Małgorzata Krajewska-Walasek, Brage S. Andresen, Niels Gregersen, Ewa Pronicka

Published in: Journal of Inherited Metabolic Disease | Special Issue 3/2010

Login to get access

Abstract

Isolated long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) is associated with c.1528G>C substitution in the HADHA gene, since most patients have the prevalent mutation on at least one allele. As it is known that the disease is relatively frequent in Europe, especially around the Baltic Sea, and that the majority of Polish LCHADD patients originate from the coastal Pomeranian province, partly inhabited by an ancient ethnic group, the Kashubians, we aimed to determine the carrier frequency of the prevalent HADHA mutation in various districts of Poland with special focus on the Kashubian district. A total of 6,854 neonatal dried blood samples from the entire country, including 2,976 Pomeranian neonates of Kashubian origin, were c.1528G>C genotyped. Fifty-nine heterozygous carriers for the prevalent c.1528G>C substitution (41 Pomeranian children) were detected in the studied group. Our data reveal a geographically skewed distribution of the c.1528C allele in the Polish population; in the northern Pomeranian province the carrier frequency is 1:73, which is the highest frequency ever reported, whereas in the remaining regions it is 1:217. Hence, the incidence of LCHADD in Poland is predicted to be 1:118,336 versus 1:16,900 in the Pomeranian district. Despite the relative rarity of the disease, screening for LCHADD in neonates born in the northern part of Poland, especially those of Kashubian origin, is justified. Our data allow us to suggest a probable Kashubian origin of the prevalent c.1528G>C mutation.
Literature
go back to reference Chmara M, Wasąg B, Żuk M et al (2010) Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations. J Appl Genet 51:95–106PubMedCrossRef Chmara M, Wasąg B, Żuk M et al (2010) Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations. J Appl Genet 51:95–106PubMedCrossRef
go back to reference Choi JH, Yoon HR, Kim GH, Park SJ, Shin YL, Yoo HW (2007) Identification of novel mutations of the HADHA and HADHB genes in patients with mitochondrial trifunctional protein deficiency. Int J Mol Med 19:81–87PubMed Choi JH, Yoon HR, Kim GH, Park SJ, Shin YL, Yoo HW (2007) Identification of novel mutations of the HADHA and HADHB genes in patients with mitochondrial trifunctional protein deficiency. Int J Mol Med 19:81–87PubMed
go back to reference Das AM, Illsinger S, Lücke T et al (2006) Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene. Clin Chem 52:530–534PubMedCrossRef Das AM, Illsinger S, Lücke T et al (2006) Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene. Clin Chem 52:530–534PubMedCrossRef
go back to reference den Boer ME, IJlst L, Wijburg FA (2000) Heterozygosity for the common LCHAD mutation (1528G>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 48:151–154CrossRef den Boer ME, IJlst L, Wijburg FA (2000) Heterozygosity for the common LCHAD mutation (1528G>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 48:151–154CrossRef
go back to reference den Boer ME, Wanders RJ, Morris AA, IJlst L, Heymans HS, Wijburg FA (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109:99–104CrossRef den Boer ME, Wanders RJ, Morris AA, IJlst L, Heymans HS, Wijburg FA (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109:99–104CrossRef
go back to reference Frazier DM, Millington DS, McCandles SM et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29:76–85PubMedCrossRef Frazier DM, Millington DS, McCandles SM et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29:76–85PubMedCrossRef
go back to reference Hagenfeldt L, Venizelos N, von Dobeln U (1995) Clinical and biochemical presentation of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 18:245–248PubMedCrossRef Hagenfeldt L, Venizelos N, von Dobeln U (1995) Clinical and biochemical presentation of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 18:245–248PubMedCrossRef
go back to reference Ibdah JA, Dasouki MJ, Strauss AW (1999) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: variable expressivity of maternal illness during pregnancy and unusual presentation with infantile cholestasis and hypocalcaemia. J Inherit Metab Dis 22:811–814PubMedCrossRef Ibdah JA, Dasouki MJ, Strauss AW (1999) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: variable expressivity of maternal illness during pregnancy and unusual presentation with infantile cholestasis and hypocalcaemia. J Inherit Metab Dis 22:811–814PubMedCrossRef
go back to reference IJlst L, Ruiter JP, Hoovers JM, Jakobs ME, Wanders RJ (1996) Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest 98:1028–1033PubMedCrossRef IJlst L, Ruiter JP, Hoovers JM, Jakobs ME, Wanders RJ (1996) Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest 98:1028–1033PubMedCrossRef
go back to reference Mordawski J (1999) Historia, geografia i piśmiennictwo Kaszubów. In: Rożak M (eds) Geografia współczesnych Kaszub. Gdańsk Mordawski J (1999) Historia, geografia i piśmiennictwo Kaszubów. In: Rożak M (eds) Geografia współczesnych Kaszub. Gdańsk
go back to reference Piekutowska-Abramczuk D, Olsen RKJ, Andresen BS et al (2005) High carrier frequencies in Poland and Denmark for the prevalent 1528G>C mutation causing long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency (LCHADD). 6th International Congress on Fatty Acid Oxidation —Clinical, Biochemical and Molecular Aspects, 8–10 June 2005, Egmond aan Zee, the Netherlands. Abstract book: 68 Piekutowska-Abramczuk D, Olsen RKJ, Andresen BS et al (2005) High carrier frequencies in Poland and Denmark for the prevalent 1528G>C mutation causing long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency (LCHADD). 6th International Congress on Fatty Acid Oxidation —Clinical, Biochemical and Molecular Aspects, 8–10 June 2005, Egmond aan Zee, the Netherlands. Abstract book: 68
go back to reference Piekutowska-Abramczuk D, Olsen RKJ, Wierzba J et al (2008) High frequency of LCHAD deficiency carriers in the northern Poland. Eur J Hum Genet 16(suppl 2):381 Piekutowska-Abramczuk D, Olsen RKJ, Wierzba J et al (2008) High frequency of LCHAD deficiency carriers in the northern Poland. Eur J Hum Genet 16(suppl 2):381
go back to reference Sander J, Sander S, Steuerwald U et al (2005) Neonatal screening for defects of the mitochondrial trifunctional protein. Mol Genet Metab 85:108–114PubMedCrossRef Sander J, Sander S, Steuerwald U et al (2005) Neonatal screening for defects of the mitochondrial trifunctional protein. Mol Genet Metab 85:108–114PubMedCrossRef
go back to reference Sykut-Cegielska J (2006) Mitochondrialne zaburzenia utleniania kwasów tłuszczowych. Rozprawa habilitacyjna, IP CZD, Warszawa Sykut-Cegielska J (2006) Mitochondrialne zaburzenia utleniania kwasów tłuszczowych. Rozprawa habilitacyjna, IP CZD, Warszawa
go back to reference Tyni T, Pihko H (1999) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr 88:237–245PubMedCrossRef Tyni T, Pihko H (1999) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr 88:237–245PubMedCrossRef
go back to reference Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348:2304–2312PubMedCrossRef Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348:2304–2312PubMedCrossRef
go back to reference Yang BZ, Heng HHQ, Ding JH, Roe CR (1996) The genes for the α- and β-subunits of the mitochondrial trifunctional protein are both located in the same region of the human chromosome 2p23. Genomics 37:141–143PubMedCrossRef Yang BZ, Heng HHQ, Ding JH, Roe CR (1996) The genes for the α- and β-subunits of the mitochondrial trifunctional protein are both located in the same region of the human chromosome 2p23. Genomics 37:141–143PubMedCrossRef
go back to reference Zhu JM, Yang Z, Yu M et al (2005) Screening for the G1528C mutation in long chain fatty acid oxidation enzyme in Han nationality in Beijing population. Beijing Da Xue Xue Bao 37:72–74PubMed Zhu JM, Yang Z, Yu M et al (2005) Screening for the G1528C mutation in long chain fatty acid oxidation enzyme in Han nationality in Beijing population. Beijing Da Xue Xue Bao 37:72–74PubMed
Metadata
Title
A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland
Authors
Dorota Piekutowska-Abramczuk
Rikke K. J. Olsen
Jolanta Wierzba
Ewa Popowska
Dorota Jurkiewicz
Elżbieta Ciara
Mariusz Ołtarzewski
Wanda Gradowska
Jolanta Sykut-Cegielska
Małgorzata Krajewska-Walasek
Brage S. Andresen
Niels Gregersen
Ewa Pronicka
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 3/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9190-7

Other articles of this Special Issue 3/2010

Journal of Inherited Metabolic Disease 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.